INCREASED BLOOD PRESSURE AND LOSS OF ANP-INDUCED NATRIURESIS IN MICE LACKING DARPP-32 GENE

REFERENCES

• Brenner B. M., Ballermann B. J., Gunning M. E., Zeidel M. L. Diverse biological actions of atrial natriuretic peptide. Physiol Rev. 1990; 70(3)665–699
   PubMed Web of Science ®Google Scholar
• Zeidel M. L., Brenner B. M. Actions of atrial natriuretic peptides on the kidney. Semin Nephrol. 1987; 7(1)91–97
   PubMed Web of Science ®Google Scholar
• Koh G., Klug M., Field L. Atrial natriuretic factor and transgenic mice. Hypertension 1993; 22: 634–639
   PubMed Web of Science ®Google Scholar
• Thompson M. W., Merril D. C., Yang G., Robillard J. E., Sigmund C. D. Transgenic animals in the study of blood pressure regulation and hypertension. Am J Physiol 1995; 269: E793–E803
   PubMed Web of Science ®Google Scholar
• Veress A. T., Chong C. K., Field L. J., Sonnenberg H. Blood pressure and fluid-electrolyte balance in ANF-transgenic mice on high- and low-salt diets. Am J Physiol 1995; 269: R186–R192
   PubMed Web of Science ®Google Scholar
• John S. W.M., Veress A. T., Honrath U., Chong C. K., Peng L., Smithies O., Sonnenberg H. Blood pressure and fluid-electrolyte balance in mice with reduced or absent ANP. Am J Physiol 1996; 271: R109–R114
   PubMed Web of Science ®Google Scholar
• Light D. B., Schwiebert E. M., Karlson K. H., Stanton B. A. Atrial natriuretic peptide inhibits a cation channel in renal medullary collecting duct cells. Science 1989; 243: 383–385
   PubMed Web of Science ®Google Scholar
• Maack T. Receptors of atrial natriuretic factor. Annu Rev Physiol 1992; 54: 11–27
   PubMed Web of Science ®Google Scholar
• Aperia A., Holt bäck U., Syrén M-L., Svensson L-B., Fryckstedt J., Greengard P. Activation/deactivation of renal tubular Na+,K+-ATPase: a common final pathway for regulation of natriuresis. FASEB J. 1994; 8: 436–439
   PubMed Web of Science ®Google Scholar
• DeLean A., Vinay P., Cantin M. Distribution of atrial natriuretic factor receptors in dog kidney fractions. FEBS Lett. 1985; 85: 239–242
   Google Scholar
• Knepper M., Lankford S., Tereda Y. Renal tubular actions of ANF. Can J Physiol Pharmacol 1991; 69: 1537–1545
   PubMed Web of Science ®Google Scholar
• Scavone C., Scanlon C., McKee M., Nathanson J. A. Atrial natriuretic peptide modulates sodium and potassium activated adenosine triphosphatase through a mechanism involving cyclic GMP and cGMP-dependent protein kinase. J Pharmacol Exp Ther. 1995; 272: 1036–1043
   PubMed Web of Science ®Google Scholar
• Snyder G. L., Girault J. A., Chen J. Y., Czernik A. J., Kebabian J. W., Nathanson J. A., Greengard P. Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine. J. Neurosci 1992; 12(8)3071–3083
   PubMed Web of Science ®Google Scholar
• Hemmings H. C., Jr., Williams K. R., Konigsberg W. H., Greengard P. DARPP-32, a dopamine- and adenosine 3′:5′ -monophosphate-regulated neurona phosphoprotein. I. Amino acid sequence around the phosphorylated threonine. J Biol Chem. 1984; 259: 14486–14490
   PubMed Web of Science ®Google Scholar
• Aperia A., Fryckstedt J., Svensson L-B., Hemmings H. C., Jr., Nairn A. C., Greengard P. Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+, K+-ATPase activity in renal tubule cells. Proc Natl Acad Sci USA 1991; 88: 2798–2801
   PubMed Web of Science ®Google Scholar
• Fienberg A. A., Hiroi N., Mermelstein P. G., Song W., Snyder G. L., Nishi A., Cheramy A., O'Callaghan J. P., Miller D. B., Cole D. G., Corbett R., Haile C. N., Cooper D. C., Onn S. P., Girault J., Nestler E. J., Greengard P. DARPP-32: Regulator of the efficacy of dopaminergic transmission. Science 1998; 281: 838–842
   PubMed Web of Science ®Google Scholar
• Holtbäck U., Ohtomo Y., Förberg P., Sahlgren B., Aperia A. Neuropeptide Y shifts equilibrium between α- andβ -adrenergic tonus in proximal tubule cells. Am J Physiol 1998; 275: F1–F7
   PubMed Web of Science ®Google Scholar
• Krege J. H., Hodgin J. B., Hagaman J. R., Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 1995; 25: 1111–1115
   PubMed Web of Science ®Google Scholar
• DeBold A. J., Borenstein H. B., Veress A. T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of myocardial extracts in rats. Life Sci. 1981; 28: 89–94
   PubMed Web of Science ®Google Scholar
• Gunning M. E., Brady H. R., Otuechre G., Brenner B. M., Zeidel M. L. Atrial natriuretic peptide (31–67) inhibits Na+-transport in rabbit inner medullary collecting duct cells. Role of prostaglandin E2. J Clin Invest. 1992; 89(5)1411–1417
   PubMed Web of Science ®Google Scholar
• Syrén M-L. Effect of atrial natriuretic factor and the fate of cyclic-guanosinemonophosphate in the rat kidney. Acta Physiol Scand. 1997; 160(1)1–7
   PubMedGoogle Scholar
• Harris A. L., Lemp B. M., Bentley R. G., Perrone M. H., Hamel L. T., Silver P. J. Phosphodiesterase isoenzyme inhibition and the potentiation by zaprinast of endothelium- derived relaxing factor and guanylate cyclase stimulatory agents in vascular smooth muscle. J Pharmacol Exp Ther. 1989; 249: 394–400
   PubMed Web of Science ®Google Scholar
• Hemmings H. C., Jr, Greengard P. DARPP-32, a dopamine- and adenosine 3′5′- monophosphate-regulated phosphoprotein: Regional, tissue, and phylogenetic distribution. J Neurosci. 1990; 6: 1469–1481
   Google Scholar
• Ouimet C. C., Miller P. E., Hemmings H. C., Jr, Walaas S. I., Greengard P. DARPP- 32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J Neurosci. 1984; 4: 111–124
   PubMed Web of Science ®Google Scholar
• Schiffmann S. N., Desdouits F., menu R., Greengard P., Vincent J. D., Vanderhaegen J. J., Girault J. A. Modulation of the voltage-gated sodium current in rat striatal neurons by DARPP-32, an inhibitor of protein phosphatase 1. Eur. J. Neurosci. 1998; 10(4)1312–1320
   PubMed Web of Science ®Google Scholar
• Snyder G. L., Fienberg A. A., Huganir R. L., Greengard P. A dopamine/D1 receptor/protein kinase A/dopamine and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of NMDA receptor. J. Neurosci. 1998; 18(24)10297–10303
   PubMed Web of Science ®Google Scholar
• Meister B., Fryckstedt J., Schalling M., Cortés R., Hökfelt T., et al. Dopamineand cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1agonist-sensitive Na+, K+-ATPase in renal tubule cells. Proc Natl Acad Sci USA 1989; 86: 8068–8072
   PubMed Web of Science ®Google Scholar
• Fryckstedt J., Aperia A., Snyder G., & Meister B. Distribution of dopamine- and cAMP-dependent phospho-protein (DARPP-32) in the developing and mature kidney. Kidney Int. 1993; 44(3)495–502
   PubMed Web of Science ®Google Scholar
• Hemmings H. C., Jr, Greengard P., Lim Tung H. Y., Cohen P. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase- 1. Nature 1984; 310: 503–508
   PubMed Web of Science ®Google Scholar
• Li D, Cheng S. X.J., Fisone G., Caplan M. J., Ohtomo Y., Aperia A. Effects of okadaic acid, calyculin A, and PDBu on state of phosphorylation of rat renal Na+,K+- ATPase. Am J Physiol. 1998; 275(6)F863–F869
   PubMed Web of Science ®Google Scholar
• Li D., Aperia A., Celsi G., da Cruz e Silva E. F., Greengard P., Meister B. Protein phosphatase-1 in the kidney: Evidence for a role in the regulation of medullary Na+,K+-ATPase. Am J Physiol. 1995; 269: F673–F680
   PubMed Web of Science ®Google Scholar
• Desdouits F., Siciliano J. C., Nairn A. C., Greengard P., Girault J-A. Dephosphorylation of Ser-137 in DARPP-32 by protein phosphatases 2A and 2C: different roles in vitro and in striatonigral neurons. Biochem J. 1998; 330: 211–216
   PubMed Web of Science ®Google Scholar
• Nishi A., Snyder G. L., Nairn A. C., Greengard P. Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons. J Neurochem. 1999; 72(5)2015–2021
   PubMed Web of Science ®Google Scholar
• Tumlin J. A., Someren J. T., Swanson C. E., Lea J. P. Expression of calcineurin activity and α-subunit isoforms in specific segments of the rat nephron. Am J Physiol. 1995; 269: F558–F563
   PubMed Web of Science ®Google Scholar
• Holtbäck U., Eklöf A-C. Mechanisms of FK520/FK506 actions on renal tubular Na+, K+-ATPase activity. Kidney Int. 1999; 56: 1014–1021
   PubMedGoogle Scholar
• Aperia A., Bertorello A., Seri I. Dopamine causes inhibition of Na+, K+-ATPase activity in proximal tubular segments. Am J Physiol 1987; 252: F39–F45
   PubMed Web of Science ®Google Scholar
• Satoh T., Cohen H. T., Katz A. I. Intracellular signaling in the regulation of renal Na+, K+-ATPase. Role of cyclic AMP and phospholipase A2. J Clin Invest. 1992; 89: 1496–1500
   PubMed Web of Science ®Google Scholar
• Needleman P., Greenwald J. E. Atriopeptin: a cardiac hormone intimately involved in fluid, elctrolyte and blood pressure homeostasis. N Engl J Med. 1986; 314: 828–834
   PubMed Web of Science ®Google Scholar
• Atlas S., Maack T. Atrial natriuretic factor. Handbook of Physiology, Renal Physiology, E. E. Windhager. Oxford University Press, New York, NY 1992; 1577–1673
   Google Scholar
• Tremblay J., Hout C., Willenbroch R. C., Bayard F., Gossard F., Fujio N., Koch C., Kuchel O., Debinski W., Hamet P. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneous hypertensive rats. J Clin Invest. 1993; 92(5)2499–2508
   PubMed Web of Science ®Google Scholar
• Albrecht F. E., Drago J., Felder R. A., Printz M., Eisner G. M., Robillard J. E., Sibley D. R., Westphal H. J., Jose P. A. Role of D1A receptor in the pathogenesis of genetic hypertension. J Clin Invest. 1996; 97(10)2283–2288
   PubMed Web of Science ®Google Scholar